Anatomical Features and System Structure
The hypothalamus and pituitary gland form a unified functional unit that serves as the central regulatory hub for the body's entire endocrine system. The anatomical structure of the pituitary is heterogeneous, which directly determines significant differences in the synthesized hormones and, consequently, the pharmacological agents used.
Traditionally, the pituitary gland is divided into two main lobes:
- Anterior lobe (adenohypophysis). This part contains specialized glandular cells. This is where "tropic" hormones are produced, whose role is to regulate the activity of peripheral endocrine glands or exert a direct effect on target tissues.
- Posterior lobe (neurohypophysis). Performs different functions in endocrine regulation.
- Notably, some mammalian species also feature a distinct intermediate lobe (pars intermedia).
Three-Tier Hierarchy and Feedback Mechanism
The general principle of neurohumoral regulation is based on a strict three-tier interaction system:
- Hypothalamic level. The hypothalamus produces specific releasing factors. These include liberins, which exert a stimulatory effect, and statins, which act as inhibitory factors.
- Pituitary level. Under the direct action of liberins, the adenohypophysis begins secreting tropic hormones.
- Target organ level. Peripheral organs respond to incoming tropic hormones by altering their function or actively secreting their own effector hormones.
The key mechanism ensuring the stability of this system is the negative feedback mechanism. Its essence is as follows: a drop in the concentration of peripheral gland hormones in the systemic circulation automatically stimulates the release of corresponding releasing hormones and tropic factors. Conversely, an excess of peripheral hormones inhibits the hypothalamus and pituitary gland. Pharmacological correction of endocrine disorders relies on endogenous hormones, their synthetic drug analogs, or specific antagonists.
Pharmacology of the Gonadotropic and Thyroid Axes
The regulatory axis for the gonads (gonadotropic axis) includes several levels. At the hypothalamic level, gonadotropin-releasing hormone (GnRH) is secreted. In clinical practice, its analog gonadorelin is used to stimulate pituitary gonadotropin secretion. At the pituitary level, follicle-stimulating hormone (FSH) and luteinizing hormone (LH) are produced. Their pharmacological analogs include menopausal gonadotropin and human chorionic gonadotropin (hCG). The target organs are the ovaries, where these agents promote follicular development, as well as the production of estrogens and progestins.
Special drugs are used to modulate the gonadotropic system:
- Danazol. This drug inhibits gonadotropin production, exerting an inhibitory effect on the pituitary gland.
- Clomiphene. Acts by blocking estrogen receptors in the hypothalamus and pituitary gland. This artificially eliminates the negative feedback mechanism, resulting in a powerful surge of gonadotropin release that triggers ovulation.
The thyroid regulatory axis (thyroid axis) operates on a similar principle. The hypothalamus secretes thyrotropin-releasing hormone (TRH), whose analog is protirelin. The pituitary responds by producing thyroid-stimulating hormone (TSH), represented in pharmacology by thyrotropin. The target organ is the thyroid gland, where follicular growth and the synthesis/secretion of thyroid hormones ($T_3$ and $T_4$) are stimulated.
Adrenal, Prolactin, and Growth Hormone Axes
- Adrenal regulatory axis (adrenal axis). The hypothalamus controls this system via corticotropin-releasing hormone (CRH). At the pituitary level, adrenocorticotropic hormone (ACTH) is secreted, with corticotropin serving as the pharmaceutical equivalent. The target organ is the adrenal cortex, which responds by producing glucocorticoids.
- Lactation regulation (prolactin axis). Characterized by dual hypothalamic control. Stimulation is provided by prolactin-releasing peptide, while dopamine serves as the primary inhibitory factor. The pituitary secretes prolactin (PRL), which acts on the mammary glands to induce lactation. To medically suppress prolactin secretion, bromocriptine, a dopamine receptor agonist, is used.
- Growth regulatory axis (somatotropic axis). Also under dual hypothalamic control. Stimulation is mediated by growth hormone-releasing hormone (GHRH), whose analog is sermorelin. Inhibition is mediated by somatostatin. Therapy utilizes octreotide, a long-acting synthetic analog of somatostatin. The pituitary releases growth hormone (GH, somatotropin), available as the drug somatotropin. Targets are peripheral tissues, where the hormone exerts its anabolic effects, stimulating tissue growth.